Memory Disorders
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
UP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UCB PharmaPiracetam
Clinical Trials (2)
Total enrollment: 676 patients across 2 trials
Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha
Phase 2Unknown
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
Start: May 2000Est. completion: Jan 2004676 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space